Nanoparticles and nanomaterials, unique modulators of the inflammatory response
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00027162%3A_____%2F19%3AN0000358" target="_blank" >RIV/00027162:_____/19:N0000358 - isvavai.cz</a>
Result on the web
<a href="https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.201970500" target="_blank" >https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.201970500</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/eji.201970500" target="_blank" >10.1002/eji.201970500</a>
Alternative languages
Result language
angličtina
Original language name
Nanoparticles and nanomaterials, unique modulators of the inflammatory response
Original language description
Various nanomaterials (NMs) of natural or industrial origin are presented in the environment. The development of new nanomaterials for various medicinal applications is driven by pharmaceutical industry and the term “biocompatibility” is required as tie-on label for any new nanomaterials intended for medicinal application. The special class of NMs is represented by carbon-based nanomaterials (CBNM) which have been recently attracted an increased attention as the NMs with the perspectives of various applications in industry and medicine. Chemical industry is capable to produce C-BNM in large quantities and, therefore, their impact on environment and hence on human health is inevitable. CBNM, predominantly graphene oxide (GO), carbon nanotubes (CNT), and nanodiamonds (ND) were tested for their potential use in nanomedicine as drug carriers. Enthusiasm of material scientists often do not reflect ability of immune system to recognise foreign structures and eliminate them by various mechanisms including inflammation.
Czech name
—
Czech description
—
Classification
Type
D - Article in proceedings
CEP classification
—
OECD FORD branch
30102 - Immunology
Result continuities
Project
<a href="/en/project/EF15_003%2F0000495" target="_blank" >EF15_003/0000495: FIT (Pharmacology, Immunotherapy, nanoToxicology)</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Article name in the collection
4th Meeting of Middle European Societies for Immunology and Allergology (MESIA)
ISBN
—
ISSN
0014-2980
e-ISSN
1521-4141
Number of pages
1
Pages from-to
72
Publisher name
European Journal of Immunology
Place of publication
Šamoín, Slovensko
Event location
Šamoín, Slovensko
Event date
Nov 28, 2019
Type of event by nationality
EUR - Evropská akce
UT code for WoS article
000497465600069